H40.41 Glaucoma secondary to eye inflammation, right eye

Name of the Condition

• Glaucoma Secondary to Eye Inflammation, Right Eye

Summary

Glaucoma secondary to eye inflammation, right eye, is a condition where increased intraocular pressure (IOP) or optic nerve damage occurs as a result of inflammatory processes in the right eye. This form of glaucoma may develop due to acute or chronic inflammation affecting the eye’s drainage structures or optic nerve, potentially leading to vision loss if not managed. The term "right eye" specifies the affected side.

Causes

The condition arises from inflammation that disrupts the eye’s normal fluid drainage or damages the optic nerve. Common mechanisms include uveitis, scleritis, or other inflammatory disorders that affect the trabecular meshwork, angle structures, or optic nerve head. Inflammation may be acute (sudden onset) or chronic (long-standing), and the underlying cause of the inflammation (e.g., autoimmune, infectious) is not specified in this code.

Risk Factors

• Chronic or recurrent eye inflammation (e.g., uveitis).
• Autoimmune conditions (e.g., rheumatoid arthritis, sarcoidosis).
• Infections affecting the eye (e.g., viral or bacterial).
• Prior eye surgery or trauma that triggers inflammation.
• Use of topical or systemic medications that induce ocular inflammation.

Symptoms

• Elevated intraocular pressure (detected via tonometry).
• Vision changes, such as blurred vision or halos around lights.
• Eye pain, redness, or discomfort.
• Progressive vision loss, particularly in peripheral fields.

Diagnosis

Diagnosis requires a thorough eye examination, including tonometry to measure IOP, gonioscopy to assess the drainage angle, and imaging (e.g., optical coherence tomography) to evaluate optic nerve damage. The right eye must be specifically documented as the affected side.

Treatment Options

Treatment focuses on reducing inflammation and lowering IOP. Options may include anti-inflammatory medications (e.g., corticosteroids), IOP-lowering drugs (e.g., prostaglandin analogs), or surgical interventions (e.g., trabeculectomy). Management of the underlying inflammatory cause is also critical.

Prognosis and Follow-Up

Prognosis depends on the severity of inflammation, IOP control, and optic nerve damage. Regular follow-up with an ophthalmologist is essential to monitor IOP, optic nerve health, and treatment response. Early intervention improves outcomes, but vision loss may be irreversible if damage is advanced.

Complications

• Permanent vision loss or blindness.
• Optic nerve damage.
• Corneal scarring or other ocular surface issues.
• Recurrent inflammation leading to treatment resistance.

Lifestyle & Prevention

• Manage underlying inflammatory conditions (e.g., autoimmune diseases) with appropriate care.
• Avoid eye trauma or injury.
• Follow prescribed medication regimens to control inflammation and IOP.
• Protect the eyes from irritants or infections.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, severe eye pain, redness, or halos around lights, as these may indicate acute pressure elevation or worsening inflammation.

Tips for Medical Coders

Document the right eye as the affected side to support this code. Ensure clinical documentation specifies glaucoma secondary to eye inflammation and the right eye involvement. Include details on inflammation type (e.g., uveitis) or underlying causes if available, but note that this code does not require specifying the inflammation’s etiology.